"Southeast BIO (SEBIO)'s mission is to foster the growth of the life sciences industry in the Southeastern United States by promoting entrepreneurship and bringing together the key stakeholders active in the development of the industry."

Glaucoma treatment device startup Camras Vision lands $5.7M

Startup Camras Vision, which is developing a device to address glaucoma, has closed on $5.7 million in venture capital funding.

Camras won the Emerging Company Award at SEBIO’s 19th Annual Investor and Partnering Forum last November.

read more

Registration Open for SEBIO 2018!!

Celebrating its 20th Anniversary, the Southeast BIO Investor & Partnering Forum returns to Atlanta on November 13-14, 2018 with a new format, new networking opportunities, and new investment prospects.

read more

UCB acquires Duke genomics startup Element for up to $30M

Element Genomics, a three-year-old Duke University spin-off focusing on genomic research, has been acquired by Belgium-based UCB for as much as $30 million.

A priority for Element is a gene-editing technology known as CRISPR.

read more